TrialJournal for immunotherapy of cancer2026

Single-cell dissection of persistent tumor antigens in non-responders reveals opportunities for TAA-targeted vaccination after neoadjuvant therapy in esophageal squamous cell carcinoma.

Ruixiang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.